Wow, MSB really leading the way (joke):Longeveron Granted Orphan Drug Designation by FDA for Lomecel-B to Treat Infants with Hypoplastic Left Heart Syndrome (HLHS)
December 6, 2021
- HLHS is a rare congenital heart defect that affects approximately 1,000 babies in the U.S. per year
- Orphan Drug Designation confers certain benefits and may result in seven year market exclusivity upon approval for this indication if all statutory and regulatory requirements are met
- Supplements Rare Pediatric Disease Designation recently granted by FDA
MIAMI, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and certain life-threatening conditions, announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for Lomecel-B for the treatment of Hypoplastic Left Heart Syndrome (HLHS), a rare and life-threatening congenital heart defect in infants.
- Forums
- ASX - By Stock
- MSB
- Ann: FDA Grants Rare Pediatric Disease Designation for Revascor
Ann: FDA Grants Rare Pediatric Disease Designation for Revascor, page-76
-
-
- There are more pages in this discussion • 305 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
92.0¢ |
Change
0.005(0.55%) |
Mkt cap ! $1.056B |
Open | High | Low | Value | Volume |
90.5¢ | 92.5¢ | 89.5¢ | $2.848M | 3.147M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 50052 | 91.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
92.0¢ | 179078 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 109942 | 0.915 |
17 | 122584 | 0.910 |
17 | 165955 | 0.905 |
18 | 480468 | 0.900 |
10 | 571783 | 0.895 |
Price($) | Vol. | No. |
---|---|---|
0.920 | 171435 | 12 |
0.925 | 131382 | 19 |
0.930 | 132219 | 12 |
0.935 | 13872 | 4 |
0.940 | 45323 | 6 |
Last trade - 15.00pm 08/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |